(Q37021684)

17 August 2017

0 references

1 reference

title

Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis (English)

1 reference

17 August 2017

0 references

0 references

1 reference

Prajesh Kothawala

1

1 reference

17 August 2017

Enkhe Badamgarav

2

1 reference

17 August 2017

Seonyoung Ryu

3

1 reference

17 August 2017

Ross M Miller

4

1 reference

17 August 2017

R J Halbert

5

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

82

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1493-1501

1 reference

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Patient adherence to osteoporosis medications: problems, consequences and management strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Review of adherence to medications for the treatment of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance with drug therapy for postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Persistence with weekly alendronate therapy among postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance with osteoporosis medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance with drug therapies for the treatment and prevention of osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Factors affecting long-term adherence to hormone replacement therapy after screening for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance with pharmacologic therapy for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Correlation between patient recall of bone densitometry results and subsequent treatment adherence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Tolerability and compliance with risedronate in clinical practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Incidence and causes for failure of treatment of women with proven osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Effects of alendronate and calcitonin on bone mineral density in postmenopausal osteoporotic women. An observational study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

The concordance of self-report with other measures of medication adherence: a summary of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Improving compliance and persistence with bisphosphonate therapy for osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

7 January 2021

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Persistence of use of lipid-lowering medications: a cross-national study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Safety of intravenous and oral bisphosphonates and compliance with dosing regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Compliance with osteoporosis drug therapy and risk of fracture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Interventions to enhance medication adherence in chronic medical conditions: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Interventions to enhance patient adherence to medication prescriptions: scientific review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Cost Effectiveness of a Pharmacy-Based Coaching Programme to Improve Adherence to Antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Cost effectiveness of an adherence-improving programme in hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Outcome-oriented cutpoints in analysis of quantitative exposures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

The assessment of refill compliance using pharmacy records: methods, validity, and applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2961093-8

10.1016/S0025-6196(11)61093-8

7 January 2021

Identifiers

DOI

1 reference

17 August 2017

1 reference